Abstract Number: 1339 • ACR/ARP Annual Meeting 2019
Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis
Background/Purpose: Immune checkpoint inhibitors (ICIs) have changed the therapeutic landscape in oncology leading to cures in some cancer types. However, patients with pre-existing autoimmune diseases…
